Abeona Therapeutics schedules Q1 2026 earnings call for May 13 to discuss financial results and progress.

Abeona Therapeutics announced it will hold a conference call on May 13, 2026, to discuss its financial results for the first quarter of 2026 and corporate developments. The call will be accessible via phone and webcast, with a replay available for 30 days. Abeona is a biopharmaceutical company specializing in cell and gene therapies, including its commercial product ZEVASKYN for treating wounds in patients with recessive dystrophic epidermolysis bullosa. This earnings call is important for investors to get updates on the company's financial health and progress in its therapeutic programs.